![Corleen Roche](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Corleen Roche
Director of Finance/CFO at
IOVANCE BIOTHERAPEUTICS, INC.
Net worth: 259 421 $ as of 2026-07-30
Profile
Corleen M.
Roche is currently Chief Financial Officer at Iovance Biotherapeutics, Inc. since 2025.
Formerly, Ms. Roche was Secretary, Chief Financial & Accounting Officer at CG Oncology, Inc. from 2024 to 2025; Chief Financial & Accounting Officer at Immunome, Inc. from 2021 to 2024; Chief Financial Officer at Biogen, Inc. from 2019 to 2021; Chief Financial Officer at Sandoz, Inc. from 2015 to 2019.
Ms. Roche also held Chief Financial Officer roles at Iogenetics LLC, CSL Behring LLC, Wyeth Pharmaceuticals, Inc., and Pfizer Inc. Ms. Roche completed undergraduate education at Villanova University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-02-28 | 2,000 ( 0% ) | 142 380 $ | 2026-07-30 | |
| 2026-08-05 | 28,757 ( 0.01% ) | 117 041 $ | 2026-07-30 |
Corleen Roche active positions
| Companies | Position | Start |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Director of Finance/CFO | 2025-08-05 |
Former positions of Corleen Roche
| Companies | Position | End |
|---|---|---|
| CG ONCOLOGY, INC. | Director of Finance/CFO | 2025-08-04 |
| IMMUNOME, INC. | Director of Finance/CFO | 2024-01-01 |
| BIOGEN INC. | Director of Finance/CFO | 2021-03-31 |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Director of Finance/CFO | 2018-12-31 |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Director of Finance/CFO | - |
Training of Corleen Roche
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
62
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Health Technology |
Immunome, Inc.
 Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
Iogenetics LLC
 Iogenetics LLC Miscellaneous Commercial ServicesCommercial Services Develops proprietary antimicrobial proteins and immunogenetics solutions | Commercial Services |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
Iovance Biotherapeutics, Inc.
 Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
CG Oncology, Inc.
 CG Oncology, Inc. BiotechnologyHealth Technology Operates as a late-stage clinical biopharmaceutical company focused on developing and commercializing backbone bladder-sparing therapeutic | Health Technology |
Wyeth Pharmaceuticals, Inc.
 Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Corleen Roche
